histamine has been researched along with Pulmonary Fibrosis in 23 studies
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the possible anti-histamine effects of dipotassium glycyrrhizinate (DG), a dipotassium salt of glycyrrhizic acid, on histamine-mediated lung fibroblast activation, differentiation and proliferation; to investigate the potential and underlying mechanisms for pulmonary fibrosis (PF) treatment." | 8.12 | Anti-histamine effects of dipotassium glycyrrhizinate on lung fibroblasts, implicating its therapeutic mechanism for pulmonary fibrosis. ( Huang, W; Zhou, X, 2022) |
| "As elevated bronchoalveolar lavage (BAL) fluid histamine levels are noted in patients with pulmonary fibrosis (PF), we assayed BAL fluid from 16 patients with PF for the presence of a histamine releasing factor (HRF)." | 7.68 | Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid. ( Broide, DH; Smith, CM; Wasserman, SI, 1990) |
| " We assessed mast-basophiloid cell numbers and histamine levels with a sensitive histamine assay, lower limit of sensitivity, 25 pg/ml, in BAL fluid from normal individuals (n = 9) and compared these results to those obtained from patients with sarcoidosis (n = 31), idiopathic pulmonary fibrosis (IPF) (n = 8), and mild asthma (n = 7)." | 7.67 | Histamine levels in bronchoalveolar lavage from patients with asthma, sarcoidosis, and idiopathic pulmonary fibrosis. ( Kaliner, M; Rankin, JA; Reynolds, HY, 1987) |
| "To examine the possible anti-histamine effects of dipotassium glycyrrhizinate (DG), a dipotassium salt of glycyrrhizic acid, on histamine-mediated lung fibroblast activation, differentiation and proliferation; to investigate the potential and underlying mechanisms for pulmonary fibrosis (PF) treatment." | 4.12 | Anti-histamine effects of dipotassium glycyrrhizinate on lung fibroblasts, implicating its therapeutic mechanism for pulmonary fibrosis. ( Huang, W; Zhou, X, 2022) |
| " Additionally, FcεRI-deficient mice showed a significantly lower score of pulmonary fibrosis than wild-type mice following exposure to silica, with significantly lower hydroxyproline content and expression of fibrotic genes Col1a1 and Fn1." | 4.12 | FcεRI deficiency alleviates silica-induced pulmonary inflammation and fibrosis. ( Chen, Y; Hou, L; Hu, H; Jiang, X; Li, Z; Pang, J; Song, M; Wang, C; Wang, J; Yang, J; Yang, P; Zhang, H; Zhang, T; Zhang, Z; Zou, X, 2022) |
| " Mast cell activation in the lung was investigated by measuring concentrations of mast cell tryptase and histamine in the bronchoalveolar lavage fluid from patients with bronchial carcinoma, sarcoidosis, extrinsic allergic alveolitis or cryptogenic fibrosing alveolitis and from normal subjects." | 3.68 | Mast cell tryptase and histamine concentrations in bronchoalveolar lavage fluid from patients with interstitial lung disease. ( Bennett, AR; Church, MK; Godfrey, RC; Holgate, ST; Walls, AF, 1991) |
| "As elevated bronchoalveolar lavage (BAL) fluid histamine levels are noted in patients with pulmonary fibrosis (PF), we assayed BAL fluid from 16 patients with PF for the presence of a histamine releasing factor (HRF)." | 3.68 | Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid. ( Broide, DH; Smith, CM; Wasserman, SI, 1990) |
| " We assessed mast-basophiloid cell numbers and histamine levels with a sensitive histamine assay, lower limit of sensitivity, 25 pg/ml, in BAL fluid from normal individuals (n = 9) and compared these results to those obtained from patients with sarcoidosis (n = 31), idiopathic pulmonary fibrosis (IPF) (n = 8), and mild asthma (n = 7)." | 3.67 | Histamine levels in bronchoalveolar lavage from patients with asthma, sarcoidosis, and idiopathic pulmonary fibrosis. ( Kaliner, M; Rankin, JA; Reynolds, HY, 1987) |
| "We measured bronchoalveolar lavage (BAL) fluid histamine in 36 normal subjects, 32 patients with sarcoidosis, and 28 patients with idiopathic pulmonary fibrosis (IPF)." | 3.67 | Bronchoalveolar lavage fluid histamine levels in interstitial lung diseases. ( Casale, TB; Hunninghake, GW; Trapp, S; Zehr, B, 1988) |
| "Pulmonary fibrosis is characterized by an inflammatory response that includes macrophages, neutrophils, lymphocytes, and mast cells." | 1.39 | Mast cells: a pivotal role in pulmonary fibrosis. ( Branch-Elliman, D; Brazin, J; Jung, A; Kaner, RJ; McGee, D; O'Connor, NJ; Reid, AC; Silver, RB; Stiles, B; Summers, B; Veerappan, A; Worgall, S, 2013) |
| "Higher counts were noted in cryptogenic fibrosing alveolitis--0." | 1.27 | Mast cell and histamine content of human bronchoalveolar lavage fluid. ( Agius, RM; Godfrey, RC; Holgate, ST, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (56.52) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W | 1 |
| Zhou, X | 1 |
| Chen, Y | 1 |
| Song, M | 1 |
| Li, Z | 1 |
| Hou, L | 1 |
| Zhang, H | 1 |
| Zhang, Z | 1 |
| Hu, H | 1 |
| Jiang, X | 1 |
| Yang, J | 1 |
| Zou, X | 1 |
| Pang, J | 1 |
| Zhang, T | 1 |
| Yang, P | 1 |
| Wang, J | 1 |
| Wang, C | 1 |
| Sgambellone, S | 1 |
| Febo, M | 1 |
| Durante, M | 1 |
| Marri, S | 1 |
| Villano, S | 1 |
| Bereshchenko, O | 1 |
| Migliorati, G | 1 |
| Masini, E | 1 |
| Riccardi, C | 1 |
| Bruscoli, S | 1 |
| Lucarini, L | 1 |
| Veerappan, A | 1 |
| O'Connor, NJ | 1 |
| Brazin, J | 1 |
| Reid, AC | 1 |
| Jung, A | 1 |
| McGee, D | 1 |
| Summers, B | 1 |
| Branch-Elliman, D | 1 |
| Stiles, B | 1 |
| Worgall, S | 1 |
| Kaner, RJ | 1 |
| Silver, RB | 1 |
| LUPU, NG | 1 |
| VELICAN, C | 1 |
| GOCIU, M | 1 |
| RACOVEANU, C | 1 |
| Goto, T | 1 |
| Befus, D | 1 |
| Low, R | 1 |
| Bienenstock, J | 1 |
| Evans, JN | 1 |
| Kelley, J | 1 |
| Krill, J | 1 |
| Low, RB | 1 |
| Adler, KB | 1 |
| Haslam, PL | 1 |
| Cromwell, O | 1 |
| Dewar, A | 1 |
| Turner-Warwick, M | 1 |
| Okada, T | 1 |
| Sugie, I | 1 |
| Aisaka, K | 1 |
| Aldenborg, F | 1 |
| Nilsson, K | 1 |
| Jarlshammar, B | 1 |
| Bjermer, L | 1 |
| Enerbäck, L | 1 |
| Eyre, P | 1 |
| Nymeyer, DH | 1 |
| McCraw, BM | 1 |
| Deline, TR | 1 |
| Chen, X | 1 |
| Walls, AF | 2 |
| Bennett, AR | 1 |
| Godfrey, RC | 3 |
| Holgate, ST | 3 |
| Church, MK | 2 |
| Broide, DH | 1 |
| Smith, CM | 1 |
| Wasserman, SI | 1 |
| Roberts, JA | 1 |
| Giri, SN | 1 |
| Hyde, DM | 1 |
| Nakashima, JM | 1 |
| Rankin, JA | 1 |
| Kaliner, M | 1 |
| Reynolds, HY | 1 |
| Keith, I | 2 |
| Day, R | 2 |
| Lemaire, S | 2 |
| Lemaire, I | 2 |
| Nadeau, D | 1 |
| Casale, TB | 1 |
| Trapp, S | 1 |
| Zehr, B | 1 |
| Hunninghake, GW | 1 |
| Baenkler, HW | 1 |
| Bäuml, T | 1 |
| Groidl, H | 1 |
| Kuriyama, T | 1 |
| Sawada, A | 1 |
| Sugita, T | 1 |
| Watanabe, S | 1 |
| Shen, SY | 1 |
| Hiroshima, K | 1 |
| Hayashi, Y | 1 |
| Agius, RM | 1 |
23 other studies available for histamine and Pulmonary Fibrosis
| Article | Year |
|---|---|
Anti-histamine effects of dipotassium glycyrrhizinate on lung fibroblasts, implicating its therapeutic mechanism for pulmonary fibrosis.
Topics: Animals; Fibroblasts; Glycyrrhizic Acid; Histamine; Lung; Pulmonary Fibrosis; Rats; Tryptases | 2022 |
FcεRI deficiency alleviates silica-induced pulmonary inflammation and fibrosis.
Topics: Animals; beta-N-Acetylhexosaminidases; Fibrosis; Histamine; Hydroxyproline; Immunoglobulin E; Interl | 2022 |
Role of histamine H
Topics: Animals; Anti-Inflammatory Agents; Glucocorticoids; Histamine; Mice; Pulmonary Fibrosis; Receptors, | 2023 |
Mast cells: a pivotal role in pulmonary fibrosis.
Topics: Angiotensin II; Animals; Antibiotics, Antineoplastic; Bleomycin; Blotting, Western; Cell Proliferati | 2013 |
[Histaminic pulmonary sclerosis. I. Microscopic aspects of the immediate changes in the respiratory parenchyma after administration of histamine].
Topics: Histamine; Histamine Agents; Pulmonary Fibrosis; Sclerosis | 1957 |
Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats.
Topics: Animals; Bleomycin; Bronchi; Cell Count; Histamine; Hyperplasia; Lung; Lymph Nodes; Male; Mast Cells | 1984 |
The myofibroblast in pulmonary fibrosis.
Topics: Acetylcholine; Actins; Epinephrine; Fibroblasts; Histamine; Humans; Muscle Contraction; Muscle, Smoo | 1983 |
Evidence of increased histamine levels of lung lavage fluids from patients with cryptogenic fibrosing alveolitis.
Topics: Adult; Aged; Body Fluids; Cell Count; Female; Histamine; Humans; Lung; Male; Mast Cells; Microscopy, | 1981 |
Effects of gamma-interferon on collagen and histamine content in bleomycin-induced lung fibrosis in rats.
Topics: Animals; Bleomycin; Collagen; Fibroblasts; Histamine; Interferon-gamma; Lung; Male; Organ Size; Pulm | 1993 |
Mast cells and biogenic amines in radiation-induced pulmonary fibrosis.
Topics: Animals; Cytoplasmic Granules; Histamine; Lung; Male; Mast Cells; Microscopy, Electron; Organelles; | 1993 |
Protection by acetylsalicylic acid and other agents in experimental acute interstitial pneumonia of calves.
Topics: Animals; Ascariasis; Aspirin; Cattle; Cattle Diseases; Histamine; Lung; Meclofenamic Acid; Methyserg | 1976 |
[Protective effect of 764-3 on experimental lung fibrosis in rats].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bleomycin; Drug Combinations; Drugs, Chinese Herba | 1992 |
Mast cell tryptase and histamine concentrations in bronchoalveolar lavage fluid from patients with interstitial lung disease.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Alveolitis, Extrinsic Allergic; Bronchoalveolar Lavage Flu | 1991 |
Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid.
Topics: beta-N-Acetylhexosaminidases; Bronchoalveolar Lavage Fluid; Colony-Stimulating Factors; Female; Gran | 1990 |
Histochemical heterogeneity of human mast cells: disease-related differences in mast cell subsets recovered by bronchoalveolar lavage.
Topics: Acetates; Acetic Acid; Adult; Aged; Aged, 80 and over; Alveolitis, Extrinsic Allergic; Bronchoalveol | 1990 |
Analysis of bronchoalveolar lavage fluid from bleomycin-induced pulmonary fibrosis in hamsters.
Topics: Acid Phosphatase; Animals; Bleomycin; Cricetinae; Glucuronidase; Histamine; Leukocyte Count; Lymphoc | 1986 |
Histamine levels in bronchoalveolar lavage from patients with asthma, sarcoidosis, and idiopathic pulmonary fibrosis.
Topics: Adult; Asthma; Histamine; Histamine Release; Humans; Immunoglobulin G; Lung; Peptidyl-Dipeptidase A; | 1987 |
Asbestos-induced fibrosis in rats: increase in lung mast cells and autacoid contents.
Topics: Animals; Asbestos; Autacoids; Formaldehyde; Histamine; Immunohistochemistry; Lung; Male; Mast Cells; | 1987 |
Changes in autacoid and neuropeptide contents of lung cells in asbestos-induced pulmonary fibrosis.
Topics: Animals; Asbestosis; Autacoids; Bombesin; Disease Models, Animal; Histamine; Lung; Male; Microscopy, | 1987 |
Bronchoalveolar lavage fluid histamine levels in interstitial lung diseases.
Topics: Analysis of Variance; Bronchoalveolar Lavage Fluid; Cell Count; Histamine; Humans; Lymphocytes; Osmo | 1988 |
In vitro histamine release from bronchial biopsy.
Topics: Adult; Aged; Biopsy; Bronchi; Bronchoscopy; Histamine; Humans; Lung Neoplasms; Middle Aged; Pulmonar | 1987 |
[Mast cell hyperplasia in monocrotaline-induced pulmonary changes in rats].
Topics: Animals; Cell Count; Histamine; Hyperplasia; Hypertension, Pulmonary; Lung; Male; Mast Cells; Monocr | 1985 |
Mast cell and histamine content of human bronchoalveolar lavage fluid.
Topics: Adult; Aged; Asthma; Bronchi; Carcinoma, Bronchogenic; Cell Count; Female; Histamine; Humans; Lung D | 1985 |